JAN 21, 2017 09:00 AM PST

3D Printed Vessels Successfully Implanted into Monkeys

WRITTEN BY: Xuan Pham

A Chinese company recently laid claim to being the first to successfully implant 3D, synthetically printed blood vessels into monkeys. Such breakthrough is predicted to pave the way for more 3D printed therapies for patients with cardiovascular diseases in the future. Furthermore, scientists hope the success of these synthetic blood vessels will provide a key puzzle piece in the development of 3D printed organs.

Located in the Sichuan capital of Chengdu, an up-and-coming hub for many start-ups, Sichuan Revotek is convinced of the potential of 3D printing in biomedicine. Last year, the company developed “the world's first 3D blood vessel bio-printer” for the purpose of producing “personalized functional organs.” This year, they’ve applied the technology to produce blood vessels that can survive after transplantation into an animal.

Sichuan Revotek credits the recent success to their patented type of bio-ink, known as “Biosynsphere.” This “ink” mixture consists of stems cells that came from the monkey’s fat tissues. In addition, the mix has a proprietary blend of growth factors and nutrients that not only keep the stem cells alive, but promote growth and attachment of these cells to the animal’s biological structures. Because the stem cells came from the monkeys’ own fat cells, the risk of rejection is lower.

In experiments, Chinese scientists implanted a 2-centimeter 3D-printed blood vessel in the abdominal artery of 30 rhesus monkeys. Within 5 days, the stem cells had differentiated into endothelial cells and smooth muscle cells, which are characteristic cells found in healthy, functioning blood vessels.

Over the course of a month, the progress was even more remarkable, as the scientists reported the integration of the 3D vessels with the monkeys’ own arteries.

This study is "the first to have maintained the viability of the cells with the 3-D printing technology," said James Kang, chief scientist and CEO of Sichuan Revotek. "And the bio-ink's capacity to develop collagen, a necessity for the tissue to mold into different shapes, is the first of its kind," he added.

Bolstered by their success, the company is seeking approval for testing in human clinical trials. “The tissues we implanted will have mingled with the original ones and grown into a regular vessel,” said researcher Kang Yujian. “This is unprecedented.”

But while other experts are also impressed with this innovation, some caution that more time is necessary to understand the stability of these 3D printed vessels. And this may take years to know. Nevertheless, Sichuan Revotek’s achievement represents an important step in 3D printed biomedicine.

Additional sources: CNN, 3DPrint, Xinhua News

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAY 22, 2018
Cancer
MAY 22, 2018
Novel PD-L1/TGF-ß Fusion Protein for HPV-Associated Cancers Enters Phase II Clinical Trial
Novel PD-L1/TGF-ß fusion protein for HPV-associated cancers enters phase II clinical trial. Oncology researchers excited about the potential of this bi-functional protein to combat cancer...
JUN 06, 2018
Clinical & Molecular DX
JUN 06, 2018
New and Improved Troponin Test for Future Heart Attack Risk
A test used by doctors in the emergency room to determine if a person is having a heart attack is now equipped to be more sensitive than ever. In addition...
JUN 21, 2018
Clinical & Molecular DX
JUN 21, 2018
Unique Gene Signature in the Blood Indicates TB Diagnosis
A unique series of genes could tell doctors that a person will develop a tuberculosis (TB) infection months before symptoms are visible. From The Francis C...
JUN 23, 2018
Clinical & Molecular DX
JUN 23, 2018
Algorithm-Based Blood Test Diagnoses Autism
As a developmental disorder, autism spectrum disorders (ASD) can be diagnosed as early as 18 to 24 months of age, but often the diagnosis does not come unt...
JUL 11, 2018
Clinical & Molecular DX
JUL 11, 2018
Certain tests better flag fetuses with brain disorder risk
Fetuses with a specific, rare chromosomal aberration have a 20 percent risk of developmental or other brain disorder, new research shows. The work could le...
AUG 06, 2018
Infographics
AUG 06, 2018
What's in your blood?
Even though we only tend to focus on four key blood types, there are actually hundreds of iterations of different proteins and other components that make u...
Loading Comments...